Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Genome & Co
AddedFeb 15, 2024
UpdatedJun 28, 2026
Genome & Co

Genome & Co

Public

Seongnam-based Genome & Company develops and markets dietary supplements, new drugs, and cosmeceuticals globally.

HQ
Seongnam, Gyeonggi, KR
Founded
2015
Overview
Compare
Fundraising
Employees

Genome & Company, based in Seongnam, South Korea, is a clinical-stage biotechnology firm focused on developing dietary supplements, new drugs, and cosmeceuticals. The company aims to innovate in the pharmaceutical sector by offering a diverse range of health-related products to a global market.

Genome & Company has made significant strides in biotechnology, contributing to advancements in health and wellness. Its global reach and innovative product line have positioned it as a key player in the pharmaceutical industry.

Genome & Co - Similar Companies

Cosmederm Bioscience logo

Cosmederm Bioscience

Geneicd logo

Geneicd

Genometry logo

Genometry

LabGenomics Co. logo

LabGenomics Co.

Cosmos Health logo

Cosmos Health

Sun Genomics logo

Sun Genomics

sungenomics.com

Xymogen logo

Xymogen

xymogen.com

Dongkoo BIO & Pharma CO. logo

Dongkoo BIO & Pharma CO.

dongkoo.com

LifeNome logo

LifeNome

GenomeNext logo

GenomeNext

Genome Insight logo

Genome Insight

Daewoong Pharmaceutical Co. logo

Daewoong Pharmaceutical Co.

daewoong.co.kr

Full Genomes logo

Full Genomes

fullgenomes.com

Genzum Life Sciences logo

Genzum Life Sciences

genzum.com

Genome Medical logo

Genome Medical

genomemedical.com

Genome & Co - Quick Facts

Who are Genome & Co's competitors?

Companies similar to Genome & Co include Cosmederm Bioscience, Geneicd, Genometry and LabGenomics Co..

When was Genome & Co founded?

Genome & Co was founded in 2015.

Where is Genome & Co's headquarters located?

Genome & Co's headquarters is located in Seongnam, Gyeonggi, KR.

When was Genome & Co's last funding round?

Genome & Co's most recent funding round was for $11B (USD) in April 2018.

How much has Genome & Co raised to-date?

As of Apr 16, 2018, Genome & Co has raised a total of $17.6B (USD).

How many employees does Genome & Co have?

Genome & Co has 105 employees as of Feb 6, 2024.

Genome & Co - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Cosmeceuticals
  • Dietary Supplements
  • New Drugs
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations